E. Sermijn

发表

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation

B. Neyns, A. De Paepe, B. Poppe, 2004, Journal of Medical Genetics.

Comparison of Methods for In-House Screening of HLA-B*57:01 to Prevent Abacavir Hypersensitivity in HIV-1 Care

J. Philippé, P. Van Acker, L. Vandekerckhove, 2015, PloS one.

INVASIVE ASPERGILLOSIS IN PATIENTS WITH CIRRHOSIS, A CASE REPORT AND REVIEW OF THE LAST 10 YEARS

H. Van Vlierberghe, E. Sermijn, D. Vogelaers, 2013, Acta clinica Belgica.

Disseminated Infection with Mycobacterium tilburgii in a Male Immunocompromised Patient

M. Vaneechoutte, P. Cools, L. Vandekerckhove, 2014, Journal of Clinical Microbiology.

Implementation of a multidisciplinary infectious diseases team in a tertiary hospital within an Antimicrobial Stewardship Program

L. Vandekerckhove, J. Boelens, G. Claeys, 2014, Acta clinica Belgica.

GLUCOCORTICOID HYPERTENSION DUE TO THE USE OF BLEACHING SKIN CREAM, A CASE REPORT.

B. Velkeniers, P. Lacor, E. Sermijn, 2005, Acta clinica Belgica.

Airborne Aspergillus fumigatus contamination in an intensive care unit: Detection, management and control.

E. Sermijn, T. Demuyser, E. De Cock, 2019, Journal of infection and public health.

CYCLIC VOMITING SYNDROME: CASE REPORT AND SHORT REVIEW OF THE LITERATURE

E. Sermijn, D. Vogelaers, K. Paemeleire, 2012, Acta clinica Belgica.

CALCIPHYLAXIS: A RARE COMPLICATION IN ALCOHOLIC LIVER DISEASE

L. Libbrecht, L. Vandekerckhove, E. Sermijn, 2013, Acta clinica Belgica.

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

E. Goetghebeur, M. Montourcy, H. Van Oyen, 2020, International Journal of Antimicrobial Agents.

De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes

W. Lissens, E. Sermijn, G. Goelen, 2005, Human mutation.

Cancer predisposing missense and protein truncating BARD1 mutations in non‐BRCA1 or BRCA2 breast cancer families

Willy Lissens, Remy Loris, R. Loris, 2010, Human mutation.

Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers.

M. Bonduelle, E. Sermijn, G. Goelen, 2007, Mutation research.

Hereditary breast cancer: from bench to bedside

E. Sermijn, E. Teugels, J. De Grève, 2008, Current opinion in oncology.

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety

M. Bonduelle, E. Sermijn, E. Teugels, 2016, Familial Cancer.

Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries

H. Goossens, P. Vanhems, K. Verhamme, 2021, The Journal of antimicrobial chemotherapy.

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety

M. Bonduelle, E. Sermijn, E. Teugels, 2016, Familial Cancer.

Comparing the performance of family characteristics and predictive models for germline BRCA1/2 mutations in breast cancer families

B. Neyns, M. Bonduelle, E. Sermijn, 2003 .

Characterization of LEDGF/p75 Genetic Variants and Association with HIV-1 Disease Progression

B. Poppe, P. Messiaen, P. Van Acker, 2012, PloS one.

Undiagnosed and comorbid disorders in patients with presumed chronic fatigue syndrome.

D. Pevernagie, E. Sermijn, D. Vogelaers, 2013, Journal of psychosomatic research.

Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017

H. Goossens, K. Verhamme, H. Jansens, 2020, Antimicrobial Resistance & Infection Control.

Optimization of a model of out-of-hospital antibiotic therapy (OPAT) in a Belgian university hospital resulting in a proposal for national implementation

C. Pattyn, E. Sermijn, S. Commeyne, 2016, Acta clinica Belgica.